Table 1.
Baseline characteristics of the sample
| Total (N = 577) | Women n = 424 (73.5%) | Men n = 153 (26.5%) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| All | NRC n = 223 | RC n = 201 | df | p | All | NRC n = 103 | RC n = 50 | df | p | ||
| Age at diagnosis - Mean (SD) | 29.30 (6.09) | 29.09 (6.00) | 27.72 (5.99) | 32.32 (5.02) | 422 | ≤.001*** | 27.76 (6.09) | 27.26 (6.24) | 28.78 (5.68) | 151 | .143 |
| Months since diagnosis - Mean (SD) | 11.89 (7.99) | 11.78 (7.60) | 11.85 (8.48) | 11.69 (6.51) | 406 | .829 | 12.22 (9.01) | 13.17 (8.97) | 10.26 (8.87) | 145 | .061 |
| N (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |||||
| Partnershipa | 391 (67.8) | 308 (73.2) | 154 (69.1) | 154 (77.8) | 1 | .044* | 83 (54.2) | 54 (52.4) | 29 (58.0) | 1 | .516 |
| Children | 184 (31.9) | 152 (35.8) | 68 (30.5) | 84 (41.8) | 1 | .015* | 32 (21.1) | 24 (23.5) | 8 (16.0) | 1 | .285 |
| Highest educational degreeb | 5 | .509 | 5 | ||||||||
| No educational degree | 6 (1.0) | 3 (0.7) | 3 (1.3) | 0 | 3 (2.0) | 3 (3.0) | 0 | ||||
| Basic educational degree (< 10 years) | 37 (6.5) | 23 (5.5) | 13 (5.8) | 10 (5.2) | 14 (9.2) | 9 (8.8) | 5 (10.0) | ||||
| Secondary educational degree (10 years) | 90 (33.2) | 128 (32.8) | 74 (33.2) | 64 (32.2) | 52 (34.2) | 34 (33.3) | 18 (36.0) | ||||
| High school degree (> 10 years) | 340 (59.3) | 257 (61.1) | 133 (59.6) | 124 (62.6) | 83 (54.5) | 56 (54.9) | 27 (54.0) | n/a | |||
| Housing/living conditionsc | 3 | ≤.001*** | 3 | .200 | |||||||
| Single | 131 (22.7) | 95 (23.6) | 49 (23.0) | 46 (12.2) | 36 (24) | 20 (19.8) | 16 (32.7) | ||||
| Living with partner | 298 (51.6) | 238 (59.1) | 110 (51.6) | 128 (67.4) | 60 (40) | 41 (40.6) | 19 (38.8) | ||||
| Living in parental household | 92 (16.6) | 51 (12.7) | 40 (18.8) | 11 (5.8) | 41 (27.3) | 32 (31.7) | 9 (18.4) | ||||
| Shared community | 32 (5.8) | 19 (4.7) | 14 (6.6) | 5 (2.6) | 13 (8.7) | 8 (7.9) | 5 (10.2) | 0 | |||
| Reproductive Cancer [C50-C57, C62] | 251 (43.5) | 201 (47.4) | n/a | 50 (32.7) | |||||||
| Non-Reproductive Cancer [All other C] | 326 (56.5) | 223 (52.6) | 103 (67.3) | n/a | |||||||
| Cancer diagnosis | n/a | n/a | |||||||||
| [C50] Breast | 150 (26.0) | 150 (35.4) | 0 | ||||||||
| [C81] Hodgkin’s Lymphoma | 99 (17.2) | 66 (15.6) | 33 (21.7) | ||||||||
| [C51-C57] Gynecological | 51 (8.8) | 51 (12.0) | 0 | ||||||||
| [C62] Testicular | 50 (8.7) | 0 | 50 (32.7) | ||||||||
| [C82-C90] Non-Hodgkin’s Lymphoma | 42 (7.3) | 22 (5.2) | 20 (13.2) | ||||||||
| Others | 41 (7.1) | 24 (5.7) | 17 (11.1) | ||||||||
| [C91-C95] Haematological | 38 (6.6) | 20 (4.7) | 16 (10.5) | ||||||||
| [C73] Thyroid | 32 (5.5) | 30 (7.1) | 2 (1.3) | ||||||||
| [C15-C26] Gastrointestinal | 29 (5.0) | 21 (5.0) | 8 (5.2) | ||||||||
| [C40-C41, C46-C49] Sarcoma | 26 (4.5) | 20 (4.7) | 6 (3.9) | ||||||||
| [C43] Melanoma | 19 (3.3) | 18 (4.2) | 1 (0.7) | ||||||||
| Therapies (multiple answers possible)d | |||||||||||
| Chemotherapye | 443 (76.8) | 310 (73.1) | 152 (68.2) | 158 (78.6) | 2 | .015* | 133 (86.9) | 91 (88.5) | 42 (84) | 2 | .454 |
| Surgery | 427 (74.0) | 325 (76.6) | 139 (62.3) | 186 (92.5) | 2 | ≤.001*** | 102 (66.7) | 54 (52.4) | 48 (96) | 2 | ≤.001*** |
| Radio and nuclear therapye | 264 (45.8) | 207 (48.8) | 92 (41.3) | 115 (57.2) | 2 | ≤.001*** | 57 (37.3) | 56 (54.4) | 1 (2) | 2 | ≤.001*** |
| Stem Cell/bone marrow transplantation | 33 (5.7) | 23 (5.5) | 21 (9.4) | 2 (1.0) | 2 | ≤.001*** | 10 (6.6) | 9 (8.7) | 1 (2) | 2 | .114 |
Males and females are listed separately and further broken down into groups of RCs and NRCs. t-tests and χ2 tests were performed between NRCs and RCs for each gender
Missing: a3 (0.5%); b4 (0.7%); c24 (4.2%); dDue to further validation there are deviations to the baseline medical therapies published in the study protocol [44]; eincluding Radio-Chemotherpy; n/a not applicable